Prawo i regulacje · 19/09/2025
DEA Adjusts 2025 Quota for Lisdexamfetamine and d-Amphetamine
The Drug Enforcement Administration is adjusting the 2025 aggregate production quota for schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion) to comply with the specified timeframes, considering factors outlined in 21 CFR 1303.13(b) and 21 U.S.C. 826(a).